A clinical research study for those with moderate to severe
If you have moderate to severe Crohn’s disease, the VIVID-1 Study may be of interest to you. The study is researching whether an investigational drug can be used to effectively treat Crohn’s disease and reduce the symptoms of this gastrointestinal disorder and participants are needed.
In order to qualify you must be:
Other eligibility criteria will apply.
Study-related care may be provided at no cost. Health insurance is not needed.
About Crohn's Disease
Crohn’s disease is a chronic inflammatory condition of the gastrointestinal tract. It belongs to a group of conditions known as inflammatory bowel diseases (IBD).
IBD affects an estimated 3 million Americans
Crohn’s disease can affect any part of the GI tract, but most commonly affects the end of the small bowel and beginning of the colon.
Crohn’s disease is most often diagnosed in adults between the ages of 20 and 30.
Inflammation of the intestine, caused by Crohn’s disease, can leave normal patches in between diseased ones.
Sources: Crohn’s and Colitis Foundation